Use of immunohistochemical markers can refine prognosis in triple negative breast cancer
-
* Corresponding author: Marc Tischkowitz marc.tischkowitz@mcgill.ca
BMC Cancer 2007, 7:134 doi:10.1186/1471-2407-7-134
Accesses
- Last 30 days: 110 accesses
- Last 365 days: 1420 accesses
- All time: 7452 accesses
Cited by
BioMed Central: 7 citations
|
Nottingham Prognostic Index in Triple-Negative Breast Cancer: a reliable prognostic tool? André Albergaria, Sara Ricardo, Fernanda Milanezi, Vítor Carneiro, Isabel Amendoeira, Daniella Vieira, Jorge Cameselle-Teijeiro, Fernando Schmitt BMC Cancer 2011, 11:299 (15 July 2011) |
|
Peeter Karihtala, Saila Kauppila, Ylermi Soini, Arja-Jukkola-Vuorinen BMC Cancer 2011, 11:262 (21 June 2011) |
|
Federico M Stefanini, Danila Coradini, Elia Biganzoli BMC Bioinformatics 2009, 10(Suppl 12):S13 (15 October 2009) |
|
Does vimentin help to delineate the so-called 'basal type breast cancer'? Renata U Kusinska, Radzislaw Kordek, Elzbieta Pluciennik, Andrzej K Bednarek, Janusz H Piekarski, Piotr Potemski Journal of Experimental & Clinical Cancer Research 2009, 28:118 (20 August 2009) |
|
Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors Marilyn L Kwan, Lawrence H Kushi, Erin Weltzien, Benjamin Maring, Susan E Kutner, Regan S Fulton, Marion M Lee, Christine B Ambrosone, Bette J Caan Breast Cancer Research 2009, 11:R31 (22 May 2009) |
|
Tatsuya Toyama, Hiroko Yamashita, Naoto Kondo, Katsuhiro Okuda, Satoru Takahashi, Hidefumi Sasaki, Hiroshi Sugiura, Hirotaka Iwase, Yoshitaka Fujii BMC Cancer 2008, 8:309 (25 October 2008) |
|
Are triple-negative tumours and basal-like breast cancer synonymous? Emad A Rakha, David SP Tan, William D Foulkes, Ian O Ellis, Andrew Tutt, Torsten O Nielsen, Jorge S Reis-Filho Breast Cancer Research 2007, 9:404 (30 November 2007) |